Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank 20 years of sampling and testing programme for medicines authorised for the EU 28 March 2019NewsHumanVeterinaryCompliance and inspections New EudraVigilance system improves reporting of side effects and detection of safety signals 27 March 2019NewsHumanVeterinaryPharmacovigilance Questions & answers: EU actions to prevent medicine shortages due to Brexit 26 March 2019NewsHerbalBrexitMedicine shortages IT systems unavailable from 30 March to 1 April 2019 26 March 2019NewsCorporate Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 19-21 March 2019 22 March 2019Press releaseVeterinaryMedicines EMA Management Board: highlights of March 2019 meeting 22 March 2019Press releaseCorporate Management Board re-elects Christa Wirthumer-Hoche as chair 21 March 2019NewsCorporateGovernance Increased risk of blood clots in lungs and death with higher dose of Xeljanz (tofacitinib) for rheumatoid arthritis 20 March 2019Press releaseHumanMedicinesPharmacovigilance Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 12-15 March 2019 15 March 2019Press releaseHumanPharmacovigilanceReferrals EMA now operating from Amsterdam 11 March 2019NewsCorporateBrexit 1 … 102 103 104 105 106 Page 106 of 380 107 108 109 110 … 380
20 years of sampling and testing programme for medicines authorised for the EU 28 March 2019NewsHumanVeterinaryCompliance and inspections
New EudraVigilance system improves reporting of side effects and detection of safety signals 27 March 2019NewsHumanVeterinaryPharmacovigilance
Questions & answers: EU actions to prevent medicine shortages due to Brexit 26 March 2019NewsHerbalBrexitMedicine shortages
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 19-21 March 2019 22 March 2019Press releaseVeterinaryMedicines
Increased risk of blood clots in lungs and death with higher dose of Xeljanz (tofacitinib) for rheumatoid arthritis 20 March 2019Press releaseHumanMedicinesPharmacovigilance
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 12-15 March 2019 15 March 2019Press releaseHumanPharmacovigilanceReferrals